Harith Rajagopalan, CEO of Fractyl Labs, envisions a scenario in which people with type 2 diabetes do not need insulin injections.
Insulin has long been a staple food for type 2 diabetes patients who need to control their blood sugar levels. However, Rajagopalan’s goal is to go beyond this temporary solution.
Rajagopalan was trained as a cardiologist and cared for patients with cardiovascular diseases and simultaneous type 2 diabetes. While serving as a cardiologist at Brigham & Women’s Hospital in Boston, his father and uncle were diagnosed with type 2 diabetes. This set the wheels in motion for Lexington, Massachusetts-based Fractyl Labs and the Revita DMR process.
You can find the full story on our sister site Drug Delivery Business News.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/01-22-2021/t_2d9960e020ed41a294e706a81858453f_name_image.jpg "‘Hell’s Kitchen’ contestant + native chef shares grilled Caesar salad & smoothie recipes"){kind=small}
